Top Clinical Trials companies in South Korea by Revenue Per Share
South Korea
# |
Name |
Revenue Per Share |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
|---|---|---|---|---|---|---|---|
| 1 |
USD 1.05
|
Dec. 31, 2023 | USD 21.07 | 1.40% |
|
South Korea |
|
| 2 |
USD 0.91
|
Dec. 31, 2023 | USD 10.57 | -0.48% |
|
South Korea |
|
| 3 |
USD 0.40
|
Dec. 31, 2023 | USD 1.67 | -1.86% |
|
South Korea |
|
| 4 |
USD 0.17
|
Dec. 31, 2023 | USD 1.17 | -3.48% |
|
South Korea |
|
| 5 |
USD 0.10
|
Dec. 31, 2023 | USD 17.25 | 0.74% |
|
South Korea |
|
| 6 |
USD 0.08
|
Dec. 31, 2023 | USD 3.70 | 0.18% |
|
South Korea |
|
| 7 |
USD 0.00
|
Dec. 31, 2023 | USD 3.10 | -1.75% |
|
South Korea |
Frequently Asked Questions
-
Which Clinical Trials company in South Korea has the highest Revenue Per Share ?
The Clinical Trials company in South Korea with the highest Revenue Per Share is ABL Bio Inc. (KOSDAQ: 298380.KQ) at USD 1.05.
-
Which Clinical Trials company in South Korea has the lowest Revenue Per Share ?
The Clinical Trials company in South Korea with the lowest Revenue Per Share is MedPacto, Inc. (KOSDAQ: 235980.KQ) at USD 0.00.
-
What are the top 10 Clinical Trials companies in South Korea by Revenue Per Share ?
The top 10 Clinical Trials companies in South Korea by Revenue Per Share are ABL Bio Inc., OliX Pharmaceuticals,Inc, GeneOne Life Science, Inc., Gencurix Inc., Oscotec Inc., Genexine, Inc. and MedPacto, Inc..
-
What are the bottom 10 Clinical Trials companies in South Korea by Revenue Per Share ?
The bottom 10 Clinical Trials companies in South Korea by Revenue Per Share are MedPacto, Inc., Genexine, Inc., Oscotec Inc., Gencurix Inc., GeneOne Life Science, Inc., OliX Pharmaceuticals,Inc and ABL Bio Inc..